SAM.gov Registered · NAICS 325414 · 325412
Federal Biologic CDMO Partner
MayMag Biologics is a SAM.gov-registered, FAR-compliant biomanufacturing subcontractor offering domestic fill-finish, sterile injectables, and biosimilar drug manufacturing for federal prime contractors, DoD programs, and GSA schedule holders.
Your Domestic Biomanufacturing Subcontractor for Federal Awards
Prime contractors and federal program offices managing pharmaceutical supply chains under GSA schedules, DoD contracts, or HHS awards need a reliable, domestic biologic CDMO partner. MayMag Biologics is registered in SAM.gov and positioned to serve as a qualified subcontractor for federal and state biomanufacturing awards.
Our Texas-based GMP facilities hold 506(e) outsourcing facility status and operate under cGMP standards aligned with FAR Part 46 quality requirements. We manufacture sterile injectables, biosimilar insulin, GLP-1 peptide APIs, and prefilled pen delivery systems — all Made in USA, Berry Amendment-aware, and TAA-compliant.
Federal Classification
NAICS Codes & Federal Classification
MayMag Biologics operates under the following NAICS codes relevant to federal pharmaceutical procurement and biomanufacturing subcontracting.
Biological Product Manufacturing
Primary classification for biosimilar insulin, GLP-1 biologics, sterile injectable biologics, and recombinant protein manufacturing at commercial scale.
Pharmaceutical Preparation Manufacturing
Covers sterile fill-finish operations, prefilled syringe assembly, autoinjector pen manufacturing, lyophilized peptide production, and oral solid dosage forms.
Drugs, Biologicals & Pharmaceutical Compounds
Federal Supply Classification for pharmaceutical and biological products procured by DoD, VA, HHS, and other federal agencies under DLA and GSA schedules.
Defense R&D — Medical Pharmaceuticals
Applicable to DoD-funded pharmaceutical research, development, and manufacturing programs including BARDA, DARPA, and DHA medical countermeasure initiatives.
Manufacturing Capabilities
Federal-Ready Manufacturing Capabilities
Our GMP facilities in Dallas and Garland, Texas are equipped to support federal biomanufacturing subcontracts across a range of dosage forms and delivery systems.
Sterile Fill-Finish — Prefilled Syringes & Biologics
Aseptic fill-finish of sterile injectable biologics into prefilled syringes, vials, and cartridges. Compliant with USP <1>, <71>, and ICH Q7 sterile manufacturing standards. Supports Berry Amendment-compliant domestic production.
Autoinjector & Pen Injector Assembly
High-volume autoinjector assembly and insulin pen OEM manufacturing for biosimilar drug delivery devices. Supports DoD and VA formulary requirements for prefilled autoinjector systems.
Biosimilar Insulin & GLP-1 Biologics
Large-scale recombinant protein production of biosimilar insulin (icodec, degludec, glargine, aspart) and GLP-1 receptor agonists. Interchangeable biosimilar insulin FDA approval pathway supported.
Lyophilized Peptide Manufacturing
GMP lyophilization of peptide APIs and finished drug products for long-term stability. Supports federal stockpile and strategic reserve pharmaceutical programs.
Large-Scale Recombinant Protein Production
Commercial-scale upstream and downstream bioprocessing for recombinant biologics. Fermentation, purification, and formulation capabilities aligned with federal BARDA and HHS biomanufacturing requirements.
Oral Solid Dosage & Specialty Formulations
Contract manufacturing of oral solid dosage forms, semi-solid topicals, and specialty pharmaceutical preparations under NAICS 325412 for federal formulary supply.
GMP-certified pharmaceutical manufacturing equipment — MayMag Biologics, Texas
Regulatory Posture
Compliance & Regulatory Framework
MayMag Biologics maintains the regulatory posture required for federal pharmaceutical subcontracting.
FAR-Compliant Contract Manufacturing
Manufacturing operations and quality systems are structured to meet Federal Acquisition Regulation (FAR) Part 46 quality assurance requirements for pharmaceutical products procured by federal agencies.
Berry Amendment-Compliant Pharmaceuticals
All manufacturing, fill-finish, and packaging operations are performed at our Texas-based US facilities, supporting Berry Amendment compliance requirements for DoD pharmaceutical procurement.
TAA-Compliant Drug Manufacturing
Products manufactured at our US facilities qualify as TAA-compliant under the Trade Agreements Act, meeting GSA schedule and federal contract requirements for country-of-origin compliance.
506(e) FDA Outsourcing Facility
Registered under Section 506(e) of the FD&C Act as a large-scale outsourcing facility, enabling commercial distribution of compounded sterile preparations to federal healthcare systems and VA hospitals.
cGMP & ICH Q7 Quality Systems
Full cGMP compliance with FDA 21 CFR Parts 210/211 and ICH Q7 Active Pharmaceutical Ingredient manufacturing guidelines. Batch records, CoA documentation, and deviation management systems in place.
Domestic Biomanufacturing Supply Chain
US-based manufacturing provides supply chain redundancy and domestic sourcing assurance for federal agencies prioritizing onshore biomanufacturing under Executive Order 14001 and BARDA domestic manufacturing initiatives.
Subcontracting Partnership
SAM.gov Subcontracting Biomanufacturing
We partner with prime contractors holding federal pharmaceutical, biodefense, and medical supply awards to provide qualified domestic biomanufacturing capacity.
Whether you are a prime contractor managing a DLA pharmaceutical supply contract, a GSA schedule holder seeking a domestic fill-finish partner, or a BARDA awardee requiring large-scale biologics manufacturing, MayMag Biologics can serve as your qualified subcontractor. Our SAM.gov registration, NAICS 325414 and 325412 classifications, and 506(e) facility status make us a compliant, audit-ready subcontracting partner for federal biomanufacturing programs.
Federal Program Use Cases
Explore Our Manufacturing Capabilities
Frequently Asked Questions
Common questions from procurement officers and prime contractors.
Is MayMag Biologics registered in SAM.gov?
Yes. MayMag Biologics is registered in SAM.gov under NAICS codes 325414 (Biological Product Manufacturing) and 325412 (Pharmaceutical Preparation Manufacturing), making us eligible to serve as a subcontractor on federal pharmaceutical and biomanufacturing awards.
What NAICS codes does MayMag Biologics hold for federal contracting?
MayMag Biologics holds NAICS 325414 for Biological Product Manufacturing and NAICS 325412 for Pharmaceutical Preparation Manufacturing. We also operate under FSC 6505 (Drugs, Biologicals, and Pharmaceutical Compounds) and are relevant to AI14 Defense R&D Medical Pharmaceuticals programs.
Are MayMag Biologics products Berry Amendment and TAA compliant?
Yes. All manufacturing, fill-finish, and packaging is performed at our Texas-based US facilities, supporting Berry Amendment compliance for DoD procurement. Products manufactured at our US facilities qualify as TAA-compliant under the Trade Agreements Act for GSA schedule and federal contract requirements.
Can MayMag Biologics serve as a subcontractor for BARDA or DLA pharmaceutical awards?
Yes. MayMag Biologics is positioned to serve as a qualified biomanufacturing subcontractor for BARDA medical countermeasure programs, DLA pharmaceutical supply contracts, VA and DoD formulary biologics, and HHS Strategic National Stockpile supply programs.
How do I request a capability statement or SAM.gov registration documentation?
Contact our business development team via the Partner with Us form. We respond within one business day with our capability statement, NAICS documentation, 506(e) registration details, and GMP certification package.
Ready to Partner on Your Federal Award?
Request our capability statement, NAICS documentation, or SAM.gov registration details. Our business development team responds within one business day.